Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study
Re G, Davide Adriano Santeufemia, Francesco Lo Re, Roberto Bortolus, Paolo Doretto, Wally Marus, Lorenzo Buttazzi, O. Lenardon, Alessandra Falda, Rita Piazza, Sandro Sulfaro
Topics & Concepts
MedicineRenal cell carcinomaChronotherapy (sleep phase)TolerabilityToxicityInternal medicineSunitinibUrologyGastroenterologyBolus (digestion)Adverse effectCircadian rhythmRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsMultiple and Secondary Primary Cancers